110 related articles for article (PubMed ID: 2573732)
1. Synthesis and pharmacological evaluation of a series of 4-piperazinylpyrazolo[3,4-b]- and -[4,3-b][1,5]benzodiazepines as potential anxiolytics.
Chakrabarti JK; Hotten TM; Pullar IA; Type NC
J Med Chem; 1989 Dec; 32(12):2573-82. PubMed ID: 2573732
[TBL] [Abstract][Full Text] [Related]
2. Effects of conformationally restricted 4-piperazinyl-10H-thienobenzodiazepine neuroleptics on central dopaminergic and cholinergic systems.
Chakrabarti JK; Hotten TM; Morgan SE; Pullar IA; Rackham DM; Risius FC; Wedley S; Chaney MO; Jones ND
J Med Chem; 1982 Oct; 25(10):1133-40. PubMed ID: 6128416
[TBL] [Abstract][Full Text] [Related]
3. [1,5-benzodiazepines. V. Synthesis of pyrazolo (3,4-b)(1,5)benzodiazepines and 5H-pyrimido(4,5-b)(1,5)benzodiazepines].
Roma G; Balbi A; Ermili A; Vigevani E
Farmaco Sci; 1983 Aug; 38(8):546-58. PubMed ID: 6137413
[TBL] [Abstract][Full Text] [Related]
4. Chemistry and pharmacology of the non-benzodiazepine anxiolytic enciprazine and related compounds.
Engel J; Fleischhauer I; Jakovlev V; Kleemann A; Kutscher B; Nickel B; Rauer H; Werner U; Szelenyi I; Johanson CE
J Med Chem; 1990 Nov; 33(11):2976-81. PubMed ID: 1977910
[TBL] [Abstract][Full Text] [Related]
5. Anxiolytic-like effect of 2-(4-((1-phenyl-1H-pyrazol-4-yl)methyl)piperazin-1-yl)ethan-1-ol is mediated through the benzodiazepine and nicotinic pathways.
Brito AF; Fajemiroye JO; Neri HFS; Silva DM; Silva DPB; Sanz G; Vaz BG; de Carvalho FS; Ghedini PC; Lião LM; Menegatti R; Costa EA
Chem Biol Drug Des; 2017 Sep; 90(3):432-442. PubMed ID: 28160425
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a series of aryl[e]fused pyrazolo[4,3-c]pyridines with potential anxiolytic activity.
Forbes IT; Johnson CN; Jones GE; Loudon J; Nicholass JM; Thompson M; Upton N
J Med Chem; 1990 Sep; 33(9):2640-5. PubMed ID: 1975276
[TBL] [Abstract][Full Text] [Related]
7. 4H-pyrrolo[1,2-a]thieno[3,2-f] and 4H-pyrrolo[1,2-a]thieno-[2,3-f][1,4]diazepines: synthesis and pharmacological evaluation.
Vega S; Gil MS; Darias V; Sánchez Mateo CC; Expósito MA; Tello ML; Albertos LM
Arch Pharm (Weinheim); 1994 Nov; 327(11):721-8. PubMed ID: 7840737
[TBL] [Abstract][Full Text] [Related]
8. Behavioral effects of nonbenzodiazepine anxiolytic drugs: a comparison of CGS 9896 and zopiclone with chlordiazepoxide.
Sanger DJ; Joly D; Zivkovic B
J Pharmacol Exp Ther; 1985 Mar; 232(3):831-7. PubMed ID: 2857789
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and pharmacological evaluation of some pyrazolo [3,4-e][1,4] diazepin-4,7-diones.
Migliara O; Flugy A; Novara V; Gagliano M
Farmaco; 1992 Jan; 47(1):111-9. PubMed ID: 1616572
[No Abstract] [Full Text] [Related]
10. Synthesis and structure-activity relationships of a series of anxioselective pyrazolopyridine ester and amide anxiolytic agents.
Bare TM; McLaren CD; Campbell JB; Firor JW; Resch JF; Walters CP; Salama AI; Meiners BA; Patel JB
J Med Chem; 1989 Dec; 32(12):2561-73. PubMed ID: 2573731
[TBL] [Abstract][Full Text] [Related]
11. Pyrazolodiazepines. 2. 4-Aryl-1,3-dialkyl-6,8-dihydropyrazolo[3,4-e] [1,4]diazepin-7(1H)-ones as antianxiety and anticonvulsant agents.
DeWald HA; Lobbestael S; Butler DE
J Med Chem; 1977 Dec; 20(12):1562-9. PubMed ID: 22748
[TBL] [Abstract][Full Text] [Related]
12. [Synthesis of pyrazolo[3,4-e][1,4]diazepine-4,7-diones with central nervous system activity].
Sprio V; Caronna S; Migliara O; Petruso S; Matera M
Farmaco; 1989 Sep; 44(9):809-18. PubMed ID: 2604835
[TBL] [Abstract][Full Text] [Related]
13. 4-Piperazinyl-10H-thieno[2,3-b][1,5]benzodiazepines as potential neuroleptics.
Chakrabarti JK; Horsman L; Hotten TM; Pullar IA; Tupper DE; Wright FC
J Med Chem; 1980 Aug; 23(8):878-84. PubMed ID: 6105216
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and anxiolytic activity of 1-phenyl-2-(4-aryl-1,3,4,5-tetrahydropyrido[2,3-b][1 ,4]diazepin-2-ylidene)-ethanone.
Liszkiewicz H; Kowalska MW; Rutkowska M; Gliniak H
Pharmazie; 2006 Jun; 61(6):517-21. PubMed ID: 16826970
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and interaction of 5-(substituted-phenyl)-3-methyl-6,7-dihydropyrazolo[4,3-e] [1,4]diazepin-8(7H)-ones with benzodiazepine receptors in rat cerebral cortex.
Baraldi PG; Manfredini S; Periotto V; Simoni D; Guarneri M; Borea PA
J Med Chem; 1985 May; 28(5):683-5. PubMed ID: 2985787
[TBL] [Abstract][Full Text] [Related]
16. Behavioural and radioligand analysis of the effect of two new piperazine derivatives with anxiolytic properties.
Danchev N; Yaneva I; Popov P; Staneva-Stoycheva D
Acta Physiol Pharmacol Bulg; 1987; 13(4):37-42. PubMed ID: 2896428
[TBL] [Abstract][Full Text] [Related]
17. 10-Piperazinyl-4H-theino[3,2-b][1,5]- and -[3,4-b][1,5]benzodiazepines as potential neuroleptics.
Chakrabarti JK; Fairhurst J; Gutteridge NJ; Horsman L; Pullar IA; Smith CW; Steggles DJ; Tupper DE; Wright FC
J Med Chem; 1980 Aug; 23(8):884-9. PubMed ID: 6105217
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacological study of 5,6,8,9-tetrahydro-4H, 7H-pyrrolo[1,2-a]cyclopenta[b]thieno[3,2-f][1,4]diazepines.
Vega S; Gil MS; Darias V; Sanchez Mateo CC; Exposito MA
Pharmazie; 1995 Jan; 50(1):27-33. PubMed ID: 7886122
[TBL] [Abstract][Full Text] [Related]
19. Notes on buspirone's mechanisms of action.
Garattini S; Caccia S; Mennini T
J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):19-24. PubMed ID: 6130069
[TBL] [Abstract][Full Text] [Related]
20. N-aminoalkylderivatives of 1,2,3,4-tetrahydro-beta-carboline-1-spiro-4'-N'- benzylpiperidine--a putative way to novel anxiolytic agents.
Bartyzel P; Misztal S; Tatarczyńska E; Chojnacka-Wójcik E
Pol J Pharmacol Pharm; 1989; 41(5):495-504. PubMed ID: 2577064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
